Laser cataract surgery patent
OptiMedica has announced that the US Patent & Trademark Office (USPTO) has granted the company a patent relating to the fundamental technology underlying laser cataract surgery. The OptiMedica patent contains broad claims and describes a 3-D image-based femtosecond laser system for performing anterior capsulotomy and lens fragmentation during the cataract procedure.
“We are gratified to see the USPTO recognise the novelty of our invention and its practical realisation in OptiMedica’s Catalys Precision Laser System,†said Dr Mark Blumenkranz, professor and chairman of the Department of Ophthalmology at Stanford University and an OptiMedica Board member. “Laser cataract surgery is an exciting new breakthrough in ophthalmology, and it has been an honor to be at the forefront of its advance,†said Dr Blumenkranz.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.